Overview
COVID-19 has caused massive disruptions to the US economy, and the food and dietary supplement industries are no exception. In this webinar, presenters will assess the impact of the current pandemic on industry manufacturing, retail, and supply chains, along with insurance and operational recovery strategies. Presenters will then engage in a broader discussion on how to prepare for the next crisis and minimize future business disruptions.
Get Access
- +$150 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Speakers
Jonathan Cohen, Partner, K&L Gates LLP
Robert Durkin, Of Counsel, Arnall Golden Gregory LLP
Lanny Schimmel, General Counsel, North America, Kerry, Inc
Moderated by Benjamin L. England, CEO & Founder, Benjamin L. England & Associates
JONATHAN COHEN is a partner in K&L Gates’ Washington, DC office, where he is a member of the Insurance Coverage practice group. His practice focuses on representing policyholders in obtaining insurance coverage in complex, multiparty disputes involving product liability, product recalls, and supply chain issues. Mr. Cohen has worked extensively with food, supplements, technology, and consumer product companies. He has successfully recovered insurance proceeds on behalf of Fortune 500 and smaller companies for a broad array of consumer product risks. Mr. Cohen served as lead counsel in numerous negotiations and in litigation involving food contamination and recall losses, Proposition 65 claims, advertising and IP claims, supply chain losses, and first-party property losses. Mr. Cohen also represents clients in managing their business risks and advises clients with respect to insurance, indemnity agreements, and other contract-related aspects of their risk management strategies. Mr. Cohen brings a unique perspective to client counseling, drawing on both his legal experience and his PhD in organizational sociology to advance his clients’ business approach to addressing risk. He also regularly represents civil rights organizations and individuals in high stakes appellate litigation. He has filed briefs for individuals, consumer and policyholder groups, asbestos trusts, and civil rights organizations in more than a dozen US Supreme Court cases, as well as before the Fourth and Ninth Circuit US Courts of Appeal and state high courts.
BENJAMIN L. ENGLAND is the CEO and Founder of Benjamin L. England & Associates, LLC and FDAImports.com, LLC . He routinely represents domestic and foreign companies of all sizes, assisting them in identifying FDA, USDA, FTC, EPA, and state requirements. His representation enables his clients to better understand and fully comply with federal and state requirements, and thereby reduce the risk of regulatory interference with products being imported, exported, or distributed in interstate commerce. A 17-year veteran of FDA, Mr. England served as the Regulatory Counsel to the Associate Commissioner for Regulatory Affairs. Before this, he served in scientific, inspectional, compliance and criminal and civil enforcement capacities as an FDA Consumer Safety Officer, Compliance Officer, a Senior Special Agent with FDA’s Office of Criminal Investigations (OCI) and an analytical regulatory microbiologist.
LANNY SCHIMMEL has been Vice President, Secretary and General Counsel of Kerry Inc., a global leader in taste and nutrition, since 2013. He is responsible for all legal matters for Kerry’s operations in North America and oversees all external counsel relationships. Prior to joining Kerry, Lanny was North American General Counsel for the Voith Group of Companies, a German manufacturing and service group, from 2004 until 2013. Lanny was Voith’s first in-house counsel in North America. From 1997 until 2004, Lanny served as Assistant City Attorney for the city of Green Bay, Wisconsin. Outside of his practice, Lanny serves as Vice Chairman of the Beloit Health System Foundation Board and was previously a member of the City of Green Bay Police and Fire Commission.
ROBERT DURKIN is of counsel in Arnall Golden Gregory LLP’s FDA and Healthcare practices and is a member of the Dietary Supplements industry team. As a former acting Director and Deputy Director of the Office of Dietary Supplement Programs (ODSP) in the FDA’s Center for Food Safety and Applied Nutrition (CFSAN), he brings a wealth of knowledge and insight to his legal practice. In working with Arnall Golden Gregory clients, Bob will draw from the extensive experience he gained at the FDA where he was responsible for performing policy analysis and evaluations related to all aspects of the agency’s dietary supplement programs, while also providing skillful advice on compliance and enforcement issues (such as Warning Letters, seizures, injunctions, import detention/refusal, etc.). During this time, he was active in a variety of agency working groups, including: Agency-wide Marijuana Working Group, Agency-wide CBD Policy Working Group, and the Agency-wide Investigational New Drug (IND) Policy Working Group. While helping to lead ODSP, Bob also successfully led the Office through multiple Government Accountability Office (GAO) investigations. Just prior to joining ODSP, Bob was the acting Director of CFSAN’s Food Defense Staff. In this role, Bob led a dedicated group of professionals whose duty it was to determine the best regulatory strategies to help protect our nation’s food supply from intentional contamination. The Food Defense staff’s work includes the implantation of the Food Safety and Modernization Act’s Rule for Mitigation Strategies to Protect Food against Intentional Adulteration and determining the best ways to educate, and then regulate, industry relative to the Rule. Bob has also served in both the Commissioner’s office and the Center for Drug Evaluation and Research (CDER). While in the Commissioner’s Office, Bob managed a staff of Emergency Response Coordinators whose focus was on coordinating an over-all Agency approach to mitigate and respond to urgent health concerns related to FDA regulated commodities. While at CDER, Bob worked in the areas of health fraud, over the counter drugs, and pharmacy compounding.Virtual Learning FAQ
Related Content
